Ambu A/S (AMBBY PINK) stock market data APIs
$12.6085
0(0%)
as of November 5, 2025
Try our APIs with
free plan!
Ambu A/S Financial Data Overview
Price chart is built with
Anychart
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, resuscitators, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
Prev. Close
12.6085
Open
12.6085
High
12.6085
Low
12.6085
52 wk Range
12.56-20.097
Market Cap
4 080 M
P/E Ratio
71.6667
Shares Outstanding
232 M
Revenue
5 958 M
EPS
0.0702
Dividends (Yield)
0.0244
Beta
1.543
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Ambu A/S data using free add-ons & libraries
Get Ambu A/S Fundamental Data
Ambu A/S Fundamental data includes:
- Net Revenue: 5 958 M
- EBITDA: 950 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-22
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ambu A/S News
New
Novo Holdings to make changes to its Board of Directors
COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ -- Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of ...
European Stocks That May Be Trading Below Their Estimated Value
As the European markets navigate a mixed landscape, with the pan-European STOXX Europe 600 Index seeing slight gains amid dovish signals from U.S. Federal Reserve officials and easing trade tensions, ...
3 European Stocks Estimated To Be Trading Up To 47.4% Below Intrinsic Value
As the European markets experience a modest uptick, with the pan-European STOXX Europe 600 Index rising amid expectations of U.S. interest rate cuts, investors are closely monitoring economic indicato...
3 European Stocks Estimated To Be Trading At Discounts Ranging From 11.4% To 32.3%
As European markets experience a boost from easing trade tensions and optimism surrounding potential U.S. interest rate cuts, major indices such as the STOXX Europe 600 and France's CAC 40 have shown ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
